[go: up one dir, main page]

CA2451271A1 - Acides nucleiques et polypeptides pancam - Google Patents

Acides nucleiques et polypeptides pancam Download PDF

Info

Publication number
CA2451271A1
CA2451271A1 CA002451271A CA2451271A CA2451271A1 CA 2451271 A1 CA2451271 A1 CA 2451271A1 CA 002451271 A CA002451271 A CA 002451271A CA 2451271 A CA2451271 A CA 2451271A CA 2451271 A1 CA2451271 A1 CA 2451271A1
Authority
CA
Canada
Prior art keywords
protein
seq
pancam
nucleic acid
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CA002451271A
Other languages
English (en)
Inventor
Alexander V. Lukashin
John P. Carulli
Daniel R. Kilburn
Chao Sun
Humphrey Athelstan Roy Gardner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogen Inc
Original Assignee
Biogen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2001/019904 external-priority patent/WO2001098360A2/fr
Application filed by Biogen Inc filed Critical Biogen Inc
Publication of CA2451271A1 publication Critical patent/CA2451271A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002451271A 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam Withdrawn CA2451271A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
USPCT/US01/19904 2001-06-22
PCT/US2001/019904 WO2001098360A2 (fr) 2000-06-22 2001-06-22 Acides nucleiques et polypeptides de gp354
PCT/US2002/020275 WO2003000021A2 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam

Publications (1)

Publication Number Publication Date
CA2451271A1 true CA2451271A1 (fr) 2003-01-03

Family

ID=21742663

Family Applications (2)

Application Number Title Priority Date Filing Date
CA002451271A Withdrawn CA2451271A1 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam
CA002459985A Abandoned CA2459985A1 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA002459985A Abandoned CA2459985A1 (fr) 2001-06-22 2002-06-24 Acides nucleiques et polypeptides pancam

Country Status (5)

Country Link
EP (1) EP1409523A4 (fr)
JP (1) JP4224395B2 (fr)
AU (1) AU2002322331B2 (fr)
CA (2) CA2451271A1 (fr)
WO (1) WO2003000021A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2021371A2 (fr) 2006-04-28 2009-02-11 Oregon Health and Science University Anticorps monoclonaux specifiques pour les cellules pancreatiques endocrines, exocrines ou ductales

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005509B1 (en) * 1995-02-17 2006-02-28 Incyte Corporation Chemokine PANEC-1 polynucleotides and compositions and methods related thereto
JPH11507845A (ja) * 1997-02-13 1999-07-13 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経細胞付着分子スプライシング変種
AU6802801A (en) * 2000-03-01 2001-09-24 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
EP1409523A4 (fr) 2005-06-15
CA2459985A1 (fr) 2003-01-03
WO2003000021A2 (fr) 2003-01-03
JP2005508147A (ja) 2005-03-31
WO2003000021A3 (fr) 2003-11-20
JP4224395B2 (ja) 2009-02-12
EP1409523A2 (fr) 2004-04-21
AU2002322331B2 (en) 2008-01-03

Similar Documents

Publication Publication Date Title
US20030211517A1 (en) Gp354 nucleic acids and polypeptides
PL211786B1 (pl) Zastosowanie przeciwciała oraz polipeptydu
EP1173456A1 (fr) Proteines secretees et acides nucleiques codant pour elles
JP2001515349A (ja) Ｔｍ４ｓｆヒト腫瘍関連抗原
US20040010119A1 (en) Novel proteins and nucleic acids encoding same
JPH10511936A (ja) ヒトソマトスタチン様受容体
AU2001270058B2 (en) GP354 nucleic acids and polypeptides
US20030165495A1 (en) Nucleic acids and polypeptides
AU761425B2 (en) Cadherin-like asymmetry protein-1, and methods for its use
AU2001270058A2 (en) GP354 nucleic acids and polypeptides
AU2001270058A1 (en) GP354 nucleic acids and polypeptides
PT2230253E (pt) Anticorpos contra um homólogo da glicoproteína p de mdr no cromossoma 7p15-21 e suas utilizações
AU2001272982B2 (en) GP286 nucleic acids and polypeptides
AU2002322331B2 (en) Pancam nucleic acids and polypeptides
JP2008517616A (ja) ｖＷＦＡ及び／又はＡＮＴ＿ＩＧドメイン含有タンパク質
EP1157032A2 (fr) Materiaux de lectomedine et procedes
AU2001272982A1 (en) GP286 nucleic acids and polypeptides
AU2002322331A1 (en) Pancam nucleic acids and polypeptides
WO2002052008A1 (fr) Nouveaux genes associes au cancer
NZ530696A (en) Pancam nucleic acids and polypeptides
WO1999045111A1 (fr) Materiaux de lectomedines et procedes associes
JP2002112784A (ja) 抗リン脂質抗体症候群治療用ｔ細胞レセプター可変領域
JP2002529053A (ja) Ｌｄｌ関連タンパク質およびその使用
JP2001514507A (ja) 癌の診断と治療のための方法および組成物
JP2003527108A (ja) ポリペプチドおよびポリペプチドをコードする核酸

Legal Events

Date Code Title Description
AZWI Withdrawn application